EX-10.15.1 30 a2233678zex-10_151.htm EX-10.15.1 Execution Version STRATEC DEVELOPMENT SERVICES AND EQUITY PARTICIPATION AGREEMENTDevelopment Services and Equity Participation Agreement • May 5th, 2020 • Delaware
THIS STRATEC DEVELOPMENT SERVICES AND EQUITY PARTICIPATION AGREEMENT (“Development Agreement”) is effective as of August, 15, 2011 (the “Effective Date”) and is made by and between STRATEC Biomedical Systems AG, a stock corporation formed under the laws of the Federal Republic of Germany, having its principal place of business at Gewerbestrasse 37, D-75217 Birkenfeld-Graefenhausen, Germany (hereinafter referred to as “STRATEC”), and Quanterix Corporation, One Kendall Square, Suite B14201, Cambridge, MA 02139 (hereinafter referred to as “QTX”, and both STRATEC and QTX are referred to as the “Parties”). The Parties enter into this Agreement pursuant to 35 U.S.C. §103 (c), and the Parties wish to create the opportunity to avail themselves, should they so desire, of the protections of the Cooperative Research and Technology Enhancement (“CREATE”) Act, P.L. 108-453 for the work conducted by them hereunder.
FIRST AMENDMENT TO STRATEC DEVELOPMENT SERVICES and EQUITY PARTICIPATION AGREEMENT and SECOND AMENDMENT TO SUPPLY and MANUFACTURING AGREEMENTDevelopment Services and Equity Participation Agreement • November 9th, 2017 • Quanterix Corp • Laboratory analytical instruments
This Amendment (the “1st and 2nd Amendment”) is made and entered into effective as of November 18, 2016, by and between Quanterix Corporation, a company organized and existing pursuant to the laws of Delaware, U.S.A. (“QTX”), and STRATEC Biomedical AG, a company organized and existing pursuant to the laws of Federal Republic of Germany (“STRATEC”). QTX and STRATEC each may be referred to herein individually as a “Party”, or collectively as the “Parties”.
